Skip to content

Testing novel biomarkers for the diagnosis of the delayed sleep wake phase disorder (DSWPD) in young adults

Testing novel biomarkers for the diagnosis of the delayed sleep wake phase disorder (DSWPD) in young adults - BT-DSWPD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030981
Enrollment
32
Registered
2022-12-23
Start date
2022-11-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47

Interventions

Group 1: Patients with suspicion for the DSWPD Diagnosis (acquired by actigraphy, sleep diary, and questionnaires) do an EEG recording during sleep, do a DLMO test and the blood and hair samples are c

Sponsors

Charitè Universitätmedizin (Chronobiology Lab)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: DSWPD Diagnosis according to ICSD-3 criteria

Exclusion criteria

Exclusion criteria: 1. Acute or chronic physical or mental illness, but excluding insomnia in the form of difficulty falling asleep (ICSD-3 criteria) and mild and moderate depression, as these are often associated with sleep problems in clinical practice. 2. Smokers (> 10 cigarettes or cigars/day) 3. Current participation in a drug trial, or if participation ended less than one month ago 4. Use of oral medication (except the contraceptive pill in women) 5. History of malignant diagnosis 6. Major surgery (including eye surgery) 7. Addiction (according to ICD 10) 8. Use of illegal substances within the last 3 months 9. Travel before inclusion in the study or the start of the experimental part: over 1 time zone within 1 week; over 2 time zones within 2 weeks, over 3 time zones within 3 weeks, over 4 time zones within the last 4 weeks.

Design outcomes

Primary

MeasureTime frame
Times, resulting from the DLMO and biomarker tests will be compared for each participant and as a distribution in the group

Secondary

MeasureTime frame
DLMO and biomarker results will be compared to the assessment of the doctors (on basis of questionnaires and actigraphy) on whether the patient should be diagnosed with DSWPD

Countries

Germany

Contacts

Public ContactAchim Kramer

Laboratory of Chronobiology

achim.kramer@charite.de+4930450524263

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026